Skip to main content
TipRanks
Go Ultimate75% OFF

Outlook Therapeutics (OTLK) Drug Pipeline

1,839 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Bevacizumab, RanibizumabAge-Related Macular Degeneration, Neovascular Age-Related Macular Degeneration, Wet Macular DegenerationPhase IIICompletedA 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects with Neovascular Age-related Macular Degeneration (AMD)Dec 19, 2023―
BevacizumabDiabetic Macular Edema, Neovascular Age-Related Macular Degeneration, Age-Related Macular Degeneration, Wet Macular Degeneration, Brvo - Branch Retinal Vein OcclusionPhase IIIActive Not RecruitingA 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal DisordersOct 28, 2021―
BevacizumabDiabetic Macular Edema, Age-Related Macular Degeneration, Neovascular Age-Related Macular Degeneration, Wet Macular Degeneration, Brvo - Branch Retinal Vein OcclusionPhase IIICompletedA 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal DisordersAug 13, 2020―
Bevacizumab, RanibizumabAge-Related Macular Degeneration, Neovascular Age-Related Macular Degeneration, Wet Macular DegenerationPhase IIICompletedA Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)Feb 14, 2019―
Bevacizumab, RanibizumabAge-Related Macular Degeneration, Neovascular Age-Related Macular Degeneration, Wet Macular DegenerationPhase IIICompletedA Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)Feb 06, 2019―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Outlook Therapeutics (OTLK) have in its pipeline
Outlook Therapeutics OTLK is currently developing the following drugs: Bevacizumab, Ranibizumab, Bevacizumab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.